Anwerina Deutschland Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Corporate

  • Financing Rounds
  • 1

Anwerina Deutschland General Information

Description

Developer and manufacturer of pharmaceutical products intended to improve the quality of life of patients with diseases or trauma to the musculoskeletal system. The company develops and manufactures pharmaceutical products with a focus on metabolic bone diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Reichskanzler-Müller-Straße 21
  • 68165 Mannheim
  • Germany
+49 0621 00000000
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • Reichskanzler-Müller-Straße 21
  • 68165 Mannheim
  • Germany
+49 0621 00000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anwerina Deutschland Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Anwerina Deutschland‘s full profile, request access.

Request a free trial

Anwerina Deutschland Patents

Anwerina Deutschland Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-102021110029-A1 Process for manufacturing a monolithic component Pending 21-Apr-2021 0000000000 0
CA-3214149-A1 Process for manufacturing a monolithic part Pending 21-Apr-2021 0000000000
EP-4326530-A1 Process for manufacturing a monolithic part Pending 21-Apr-2021 0000000000
US-20240165871-A1 Process for manufacturing a monolithic part Pending 21-Apr-2021 0000000000
US-20190290756-A1 Pharmaceutical compositions with anti-rankl antibodies, calcium and vitamin d Inactive 20-May-2016 A61K39/3955 0
To view Anwerina Deutschland’s complete patent history, request access »

Anwerina Deutschland Executive Team (2)

Name Title Board Seat
Christoph Karl Managing Director
Michaela Werner Managing Director
To view Anwerina Deutschland’s complete executive team members history, request access »

Anwerina Deutschland Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anwerina Deutschland Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Anwerina Deutschland‘s full profile, request access.

Request a free trial

Anwerina Deutschland FAQs

  • When was Anwerina Deutschland founded?

    Anwerina Deutschland was founded in 2009.

  • Where is Anwerina Deutschland headquartered?

    Anwerina Deutschland is headquartered in Mannheim, Germany.

  • What is the size of Anwerina Deutschland?

    Anwerina Deutschland has 12 total employees.

  • What industry is Anwerina Deutschland in?

    Anwerina Deutschland’s primary industry is Pharmaceuticals.

  • Is Anwerina Deutschland a private or public company?

    Anwerina Deutschland is a Private company.

  • What is Anwerina Deutschland’s current revenue?

    The current revenue for Anwerina Deutschland is 000000.

  • Who are Anwerina Deutschland’s investors?

    Riemser Pharma has invested in Anwerina Deutschland.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »